Brief: Theravance Biopharma Q3 Operating Income USD -10.837 Million
12/11/2024 21:05
Nov 12 (Reuters) - Theravance Biopharma Q3 net income USD -12.698 million. * Q3 adjusted net income USD -2.897 million vs. IBES estimate USD -11.2 million
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions